Europe In Vitro Diagnotics Investment Opportunities, Analysis and Forecasts to 2015
Global Markets Direct
December 29, 2009 224 Pages - SKU: GMD2553799
|
|
Countries covered: Europe
Europe In Vitro Diagnotics Investment Opportunities, Analysis and Forecasts to 2015
Summary
This report is an essential source for in-depth information and data relating to Europe In vitro diagnostics market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Europe
Scope- The report provides information on the European in vitro diagnostics market, broken down into detailed categories and segments including In Vitro Diagnostics Devices, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.
- Market shares of all the key competitors including F. Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., and Siemens Medical Solutions, amongst others.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.
Reasons to buy- Gain a strong understanding of the in vitro diagnostics devices market in Europe.
- Evaluate and compare the attractiveness of the market in the region.
- Identify growth segments and opportunities in each industry sector within the region.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the region.
- Analyze the competitiveness of the market in the region and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the region.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the region.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the region.
|
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 3 Definitions of the Markets Covered in the Report
- 3.1 In Vitro Diagnostics
- 3.2 Clinical Chemistry
- 3.3 Genetic Testing
- 3.4 Haematology
- 3.5 Histology And Cytology
- 3.6 Immuno Chemistry
- 3.7 Infectious Immunology
- 3.8 Microbiology Culture
- 4 In Vitro Diagnostics in Europe
- 4.1 In Vitro Diagnostics, Europe, Overall Revenue ($ mn), 2000-2015
- 4.2 In Vitro Diagnostics, Europe, Company share (2007-2008)
- 5 In Vitro Diagnostics In Germany
- 5.1 In Vitro Diagnostics, Germany, Overall Revenue ($ mn), 2000-2015
- 5.2 In Vitro Diagnostics, Germany, Distribution Share (2007-2008)
- 5.2.1 Clinical Chemistry Distribution Share (2007-2008)
- 5.2.2 Genetic Testing Distribution Share (2007-2008)
- 5.2.3 Haematology Distribution Share (2007-2008)
- 5.2.4 Histology And Cytology Distribution Share (2007-2008)
- 5.2.5 Immuno Chemistry Distribution Share (2007-2008)
- 5.2.6 Infectious Immunology Distribution Share (2007-2008)
- 5.2.7 Microbiology Culture Distribution Share (2007-2008)
- 5.3 In Vitro Diagnostics, Germany, Company Share (2007-2008)
- 5.3.1 In Vitro Diagnostics, Germany, Company Share (2007-2008)
- 5.3.2 Clinical Chemistry, Germany, Company Share (2007-2008)
- 5.3.3 Genetic Testing, Germany, Company Share (2007-2008)
- 5.3.4 Haematology, Germany, Company Share (2007-2008)
- 5.3.5 Histology And Cytology, Germany, Company Share (2007-2008)
- 5.3.6 Immuno Chemistry, Germany, Company Share (2007-2008)
- 5.3.7 Infectious Immunology, Germany, Company Share (2007-2008)
- 5.3.8 Microbiology Culture, Germany, Company Share (2007-2008)
- 6 In Vitro Diagnostics In France
- 6.1 In Vitro Diagnostics, France, Overall Revenue ($ mn), 2000-2015
- 6.2 In Vitro Diagnostics, France, Distribution Share (2007-2008)
- 6.2.1 Clinical Chemistry Distribution Share (2007-2008)
- 6.2.2 Genetic Testing Distribution Share (2007-2008)
- 6.2.3 Haematology Distribution Share (2007-2008)
- 6.2.4 Histology And Cytology Distribution Share (2007-2008)
- 6.2.5 Immuno Chemistry Distribution Share (2007-2008)
- 6.2.6 Infectious Immunology Distribution Share (2007-2008)
- 6.2.7 Microbiology Culture Distribution Share (2007-2008)
- 6.3 In Vitro Diagnostics, France, Company Share (2007-2008)
- 6.3.1 In Vitro Diagnostics, France, Company Share (2007-2008)
- 6.3.2 Clinical Chemistry, France, Company Share (2007-2008)
- 6.3.3 Genetic Testing, France, Company Share (2007-2008)
- 6.3.4 Haematology, France, Company Share (2007-2008)
- 6.3.5 Histology And Cytology, France, Company Share (2007-2008)
- 6.3.6 Immuno Chemistry, France, Company Share (2007-2008)
- 6.3.7 Infectious Immunology, France, Company Share (2007-2008)
- 6.3.8 Microbiology Culture, France, Company Share (2007-2008)
- 7 In Vitro Diagnostics In United Kingdom
- 7.1 In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), 2000-2015
- 7.2 In Vitro Diagnostics, United Kingdom, Distribution Share (2007-2008)
- 7.2.1 Clinical Chemistry Distribution Share (2007-2008)
- 7.2.2 Genetic Testing Distribution Share (2007-2008)
- 7.2.3 Haematology Distribution Share (2007-2008)
- 7.2.4 Histology And Cytology Distribution Share (2007-2008)
- 7.2.5 Immuno Chemistry Distribution Share (2007-2008)
- 7.2.6 Infectious Immunology Distribution Share (2007-2008)
- 7.2.7 Microbiology Culture Distribution Share (2007-2008)
- 7.3 In Vitro Diagnostics, United Kingdom, Company Share (2007-2008)
- 7.3.1 In Vitro Diagnostics, United Kingdom, Company Share (2007-2008)
- 7.3.2 Clinical Chemistry, United Kingdom, Company Share (2007-2008)
- 7.3.3 Genetic Testing, United Kingdom, Company Share (2007-2008)
- 7.3.4 Haematology, United Kingdom, Company Share (2007-2008)
- 7.3.5 Histology And Cytology, United Kingdom, Company Share (2007-2008)
- 7.3.6 Immuno Chemistry, United Kingdom, Company Share (2007-2008)
- 7.3.7 Infectious Immunology, United Kingdom, Company Share (2007-2008)
- 7.3.8 Microbiology Culture, United Kingdom, Company Share (2007-2008)
- 8 In Vitro Diagnostics In Italy
- 8.1 In Vitro Diagnostics, Italy, Overall Revenue ($ mn), 2000-2015
- 8.2 In Vitro Diagnostics, Italy, Distribution Share (2007-2008)
- 8.2.1 Clinical Chemistry Distribution Share (2007-2008)
- 8.2.2 Genetic Testing Distribution Share (2007-2008)
- 8.2.3 Haematology Distribution Share (2007-2008)
- 8.2.4 Histology And Cytology Distribution Share (2007-2008)
- 8.2.5 Immuno Chemistry Distribution Share (2007-2008)
- 8.2.6 Infectious Immunology Distribution Share (2007-2008)
- 8.2.7 Microbiology Culture Distribution Share (2007-2008)
- 8.3 In Vitro Diagnostics, Italy, Company Share (2007-2008)
- 8.3.1 In Vitro Diagnostics, Italy, Company Share (2007-2008)
- 8.3.2 Clinical Chemistry, Italy, Company Share (2007-2008)
- 8.3.3 Genetic Testing, Italy, Company Share (2007-2008)
- 8.3.4 Haematology, Italy, Company Share (2007-2008)
- 8.3.5 Histology And Cytology, Italy, Company Share (2007-2008)
- 8.3.6 Immuno Chemistry, Italy, Company Share (2007-2008)
- 8.3.7 Infectious Immunology, Italy, Company Share (2007-2008)
- 8.3.8 Microbiology Culture, Italy, Company Share (2007-2008)
- 9 In Vitro Diagnostics In Spain
- 9.1 In Vitro Diagnostics, Spain, Overall Revenue ($ mn), 2000-2015
- 9.2 In Vitro Diagnostics, Spain, Distribution Share (2007-2008)
- 9.2.1 Clinical Chemistry Distribution Share (2007-2008)
- 9.2.2 Genetic Testing Distribution Share (2007-2008)
- 9.2.3 Haematology Distribution Share (2007-2008)
- 9.2.4 Histology And Cytology Distribution Share (2007-2008)
- 9.2.5 Immuno Chemistry Distribution Share (2007-2008)
- 9.2.6 Infectious Immunology Distribution Share (2007-2008)
- 9.2.7 Microbiology Culture Distribution Share (2007-2008)
- 9.3 In Vitro Diagnostics, Spain, Company Share (2007-2008)
- 9.3.1 In Vitro Diagnostics, Spain, Company Share (2007-2008)
- 9.3.2 Clinical Chemistry, Spain, Company Share (2007-2008)
- 9.3.3 Genetic Testing, Spain, Company Share (2007-2008)
- 9.3.4 Haematology, Spain, Company Share (2007-2008)
- 9.3.5 Histology And Cytology, Spain, Company Share (2007-2008)
- 9.3.6 Immuno Chemistry, Spain, Company Share (2007-2008)
- 9.3.7 Infectious Immunology, Spain, Company Share (2007-2008)
- 9.3.8 Microbiology Culture, Spain, Company Share (2007-2008)
- 10 In Vitro Diagnostics In Netherlands
- 10.1 In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), 2000-2015
- 10.2 In Vitro Diagnostics, Netherlands, Distribution Share (2007-2008)
- 10.2.1 Clinical Chemistry Distribution Share (2007-2008)
- 10.2.2 Genetic Testing Distribution Share (2007-2008)
- 10.2.3 Haematology Distribution Share (2007-2008)
- 10.2.4 Histology And Cytology Distribution Share (2007-2008)
- 10.2.5 Immuno Chemistry Distribution Share (2007-2008)
- 10.2.6 Infectious Immunology Distribution Share (2007-2008)
- 10.2.7 Microbiology Culture Distribution Share (2007-2008)
- 10.3 In Vitro Diagnostics, Netherlands, Company Share (2007-2008)
- 10.3.1 In Vitro Diagnostics, Netherlands, Company Share (2007-2008)
- 10.3.2 Clinical Chemistry, Netherlands, Company Share (2007-2008)
- 10.3.3 Genetic Testing, Netherlands, Company Share (2007-2008)
- 10.3.4 Haematology, Netherlands, Company Share (2007-2008)
- 10.3.5 Histology And Cytology, Netherlands, Company Share (2007-2008)
- 10.3.6 Immuno Chemistry, Netherlands, Company Share (2007-2008)
- 10.3.7 Infectious Immunology, Netherlands, Company Share (2007-2008)
- 10.3.8 Microbiology Culture, Netherlands, Company Share (2007-2008)
- 11 In Vitro Diagnostics In Belgium
- 11.1 In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), 2000-2015
- 11.2 In Vitro Diagnostics, Belgium, Distribution Share (2007-2008)
- 11.2.1 Clinical Chemistry Distribution Share (2007-2008)
- 11.2.2 Genetic Testing Distribution Share (2007-2008)
- 11.2.3 Haematology Distribution Share (2007-2008)
- 11.2.4 Histology And Cytology Distribution Share (2007-2008)
- 11.2.5 Immuno Chemistry Distribution Share (2007-2008)
- 11.2.6 Infectious Immunology Distribution Share (2007-2008)
- 11.2.7 Microbiology Culture Distribution Share (2007-2008)
- 11.3 In Vitro Diagnostics, Belgium, Company Share (2007-2008)
- 11.3.1 In Vitro Diagnostics, Belgium, Company Share (2007-2008)
- 11.3.2 Clinical Chemistry, Belgium, Company Share (2007-2008)
- 11.3.3 Genetic Testing, Belgium, Company Share (2007-2008)
- 11.3.4 Haematology, Belgium, Company Share (2007-2008)
- 11.3.5 Histology And Cytology, Belgium, Company Share (2007-2008)
- 11.3.6 Immuno Chemistry, Belgium, Company Share (2007-2008)
- 11.3.7 Infectious Immunology, Belgium, Company Share (2007-2008)
- 11.3.8 Microbiology Culture, Belgium, Company Share (2007-2008)
- 12 Overview of Key Companies in Europe In Vitro Diagnostics Market
- 12.1 Ventana Medical Systems, Inc.
- 12.1.1 Company Overview
- 12.2 Sysmex Corporation
- 12.2.1 Company Overview
- 12.2.2 Sysmex Corporation Pipeline Products
- 12.3 Siemens Healthcare
- 12.3.1 Company Overview
- 12.4 Qiagen N.V.
- 12.4.1 Company Overview
- 12.4.2 Qiagen N.V. Pipeline Products
- 12.5 Phadia AB
- 12.5.1 Company Overview
- 12.5.2 Phadia AB Pipeline Products
- 12.6 Ortho-Clinical Diagnostics Inc.
- 12.6.1 Company Overview
- 12.6.2 Ortho-Clinical Diagnostics Inc. Pipeline Products
- 12.7 Mindray Medical International Limited
- 12.7.1 Company Overview
- 12.7.2 Mindray Medical International Limited Pipeline Products
- 12.8 Inverness Medical Innovations, Inc.
- 12.8.1 Company Overview
- 12.8.2 Inverness Medical Innovations, Inc. Pipeline Products
- 12.9 Hologic, Inc.
- 12.9.1 Company Overview
- 12.9.2 Hologic, Inc. Pipeline Products
- 12.10 Gen-Probe Incorporated
- 12.10.1 Company Overview
- 12.10.2 Gen-Probe Incorporated Pipeline Products
- 12.11 F. Hoffmann-La Roche Ltd.
- 12.11.1 Company Overview
- 12.12 Digene Corporation
- 12.12.1 Company Overview
- 12.13 Dade Behring Holdings, Inc.
- 12.13.1 Company Overview
- 12.14 DiaSorin S.p.A
- 12.14.1 Company Overview
- 12.14.2 DiaSorin S.p.A Pipeline Products
- 12.15 Bio-Rad Laboratories, Inc.
- 12.15.1 Company Overview
- 12.16 bioMerieux S.A.
- 12.16.1 Company Overview
- 12.16.2 Biomerieux Sa Pipeline Products
- 12.17 Becton, Dickinson and Company
- 12.17.1 Company Overview
- 12.17.2 Becton, Dickinson and Company Pipeline Products
- 12.18 Beckman Coulter, Inc.
- 12.18.1 Company Overview
- 12.18.2 Beckman Coulter, Inc. Pipeline Products
- 12.19 Abbott Laboratories
- 12.19.1 Company Overview
- 12.19.2 Abbott Laboratories Pipeline Products
- 13 Financial Deals Landscape
- 13.1 Acquisition
- 13.1.1 Lab21 Acquires Delphic Diagnostic From BDO
- 13.1.2 International SOS Acquires Majority Stake In Abermed
- 13.1.3 Bio-Rad Laboratories To Acquire Medical Diagnostics Segment From Biotest
- 13.1.4 ERBA DIAGNOSTICS MANNHEIM Acquires PLIVA-Lachema Diagnostika
- 13.1.5 Thermo Fisher Scientific Completes Acquisition Of B.R.A.H.M.S.
- 13.1.6 QIAGEN Completes Acquisition Of DxS
- 13.2 Private Equity
- 13.2.1 Legal & General Ventures To Sell LGC
- 13.2.2 LinkMed To Acquire 51% Stake In AbSorber From Koncentra And Jan Holgersson
- 13.2.3 North Atlantic Value Completes Acquisition Of Celsis International
- 13.2.4 The Riverside Acquires Crioestaminal Saude e Tecnologia
- 13.3 Venture Financing
- 13.3.1 Curetis Secures $27.89 Million In Series A Round Of Financing
- 13.3.2 Biomedical Diagnostics Secures $4.52 Million In Financing
- 13.3.3 Pronota Secures Additional $1.92 Million In Series B Round Of Financing
- 13.3.4 Biocartis Secures $14.9 Million In Series A Equity Round Of Financing
- 13.3.5 mtm laboratories Secures $10.21 Million In Fourth Tranche Of Series C Financing Round
- 13.3.6 Kreatech Diagnostics Secures $2.86 Million In Financing Round
- 13.3.7 Agendia Raises $23 Million In Series E Financing
- 13.4 Equity Offerings
- 13.4.1 ExonHit Therapeutics Plans Rights Issue Of New Shares For $25.67 Million
- 13.4.2 Osmetech Announces Private Placement Of Shares For $16.3 Million
- 13.4.3 Mediwatch Completes Private Placement Of $0.57 Million
- 13.4.4 QIAGEN Completes Private Placement Of Its Common Stock For $640 Million
- 13.5 Partnerships
- 13.5.1 HairDX Enters Into Distribution Agreement With Svenson Haar Studios
- 13.5.2 MabCure Signs Research Agreement With AZ Sint-Lucas
- 14 APPENDIX
- 14.1 Global Markets Direct Research Methodology
- 14.2 Secondary Research
- 14.3 Primary Research
- 14.4 Models
- 14.5 Forecasts
- 14.6 Expert Panel Validation
- 14.7 Currency Conversion
- 14.8 Contact Us
- 14.9 Disclaimer
- 1.1 List of Tables
- Table 1: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), 2000-2015
- Table 2: Europe In Vitro Diagnostics Market, Cross-Category Analysis, 2000-2015
- Table 3: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), Historic, 2000-2008
- Table 4: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), Forecast, 2008-2015
- Table 5: In Vitro Diagnostics, Europe, Company share by Revenue ($ mn), 2007-2008
- Table 6: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), 2000-2015
- Table 7: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Historic, 2000-2008
- Table 8: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Forecast, 2008-2015
- Table 9: Clinical Chemistry, Germany, Distribution Share by Revenue ($mn), 2007-2008
- Table 10: Genetic Testing, Germany, Distribution Share by Revenue ($mn), 2007-2008
- Table 11: Haematology, Germany, Distribution Share by Revenue ($mn), 2007-2008
- Table 12: Histology And Cytology, Germany, Distribution Share by Revenue ($mn), 2007-2008
- Table 13: Immuno Chemistry, Germany, Distribution Share by Revenue ($mn), 2007-2008
- Table 14: Infectious Immunology, Germany, Distribution Share by Revenue ($mn), 2007-2008
- Table 15: Microbiology Culture, Germany, Distribution Share by Revenue ($mn), 2007-2008
- Table 16: In Vitro Diagnostics, Germany, Company Share by Revenue ($ mn), 2007-2008
- Table 17: Clinical Chemistry, Germany, Company Share by Revenue ($ mn), 2007-2008
- Table 18: Genetic Testing, Germany, Company Share by Revenue ($ mn), 2007-2008
- Table 19: Haematology, Germany, Company Share by Revenue ($ mn), 2007-2008
- Table 20: Histology And Cytology, Germany, Company Share by Revenue ($ mn), 2007-2008
- Table 21: Immuno Chemistry, Germany, Company Share by Revenue ($ mn), 2007-2008
- Table 22: Infectious Immunology, Germany, Company Share by Revenue ($ mn), 2007-2008
- Table 23: Microbiology Culture, Germany, Company Share by Revenue ($ mn), 2007-2008
- Table 24: In Vitro Diagnostics, France, Overall Revenue ($ mn), 2000-2015
- Table 25: In Vitro Diagnostics, France, Overall Revenue ($ mn), Historic, 2000-2008
- Table 26: In Vitro Diagnostics, France, Overall Revenue ($ mn), Forecast, 2008-2015
- Table 27: Clinical Chemistry, France, Distribution Share by Revenue ($mn), 2007-2008
- Table 28: Genetic Testing, France, Distribution Share by Revenue ($mn), 2007-2008
- Table 29: Haematology, France, Distribution Share by Revenue ($mn), 2007-2008
- Table 30: Histology And Cytology, France, Distribution Share by Revenue ($mn), 2007-2008
- Table 31: Immuno Chemistry, France, Distribution Share by Revenue ($mn), 2007-2008
- Table 32: Infectious Immunology, France, Distribution Share by Revenue ($mn), 2007-2008
- Table 33: Microbiology Culture, France, Distribution Share by Revenue ($mn), 2007-2008
- Table 34: In Vitro Diagnostics, France, Company Share by Revenue ($ mn), 2007-2008
- Table 35: Clinical Chemistry, France, Company Share by Revenue ($ mn), 2007-2008
- Table 36: Genetic Testing, France, Company Share by Revenue ($ mn), 2007-2008
- Table 37: Haematology, France, Company Share by Revenue ($ mn), 2007-2008
- Table 38: Histology And Cytology, France, Company Share by Revenue ($ mn), 2007-2008
- Table 39: Immuno Chemistry, France, Company Share by Revenue ($ mn), 2007-2008
- Table 40: Infectious Immunology, France, Company Share by Revenue ($ mn), 2007-2008
- Table 41: Microbiology Culture, France, Company Share by Revenue ($ mn), 2007-2008
- Table 42: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), 2000-2015
- Table 43: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008
- Table 44: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015
- Table 45: Clinical Chemistry, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
- Table 46: Genetic Testing, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
- Table 47: Haematology, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
- Table 48: Histology And Cytology, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
- Table 49: Immuno Chemistry, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
- Table 50: Infectious Immunology, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
- Table 51: Microbiology Culture, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008
- Table 52: In Vitro Diagnostics, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
- Table 53: Clinical Chemistry, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
- Table 54: Genetic Testing, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
- Table 55: Haematology, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
- Table 56: Histology And Cytology, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
- Table 57: Immuno Chemistry, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
- Table 58: Infectious Immunology, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
- Table 59: Microbiology Culture, United Kingdom, Company Share by Revenue ($ mn), 2007-2008
- Table 60: In Vqitro Diagnostics, Italy, Overall Revenue ($ mn), 2000-2015
- Table 61: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Historic, 2000-2008
- Table 62: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Forecast, 2008-2015
- Table 63: Clinical Chemistry, Italy, Distribution Share by Revenue ($mn), 2007-2008
- Table 64: Genetic Testing, Italy, Distribution Share by Revenue ($mn), 2007-2008
- Table 65: Haematology, Italy, Distribution Share by Revenue ($mn), 2007-2008
- Table 66: Histology And Cytology, Italy, Distribution Share by Revenue ($mn), 2007-2008
- Table 67: Immuno Chemistry, Italy, Distribution Share by Revenue ($mn), 2007-2008
- Table 68: Infectious Immunology, Italy, Distribution Share by Revenue ($mn), 2007-2008
- Table 69: Microbiology Culture, Italy, Distribution Share by Revenue ($mn), 2007-2008
- Table 70: In Vitro Diagnostics, Italy, Company Share by Revenue ($ mn), 2007-2008
- Table 71: Clinical Chemistry, Italy, Company Share by Revenue ($ mn), 2007-2008
- Table 72: Genetic Testing, Italy, Company Share by Revenue ($ mn), 2007-2008
- Table 73: Haematology, Italy, Company Share by Revenue ($ mn), 2007-2008
- Table 74: Histology And Cytology, Italy, Company Share by Revenue ($ mn), 2007-2008
- Table 75: Immuno Chemistry, Italy, Company Share by Revenue ($ mn), 2007-2008
- Table 76: Infectious Immunology, Italy, Company Share by Revenue ($ mn), 2007-2008
- Table 77: Microbiology Culture, Italy, Company Share by Revenue ($ mn), 2007-2008
- Table 78: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), 2000-2015
- Table 79: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Historic, 2000-2008
- Table 80: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Forecast, 2008-2015
- Table 81: Clinical Chemistry, Spain, Distribution Share by Revenue ($mn), 2007-2008
- Table 82: Genetic Testing, Spain, Distribution Share by Revenue ($mn), 2007-2008
- Table 83: Haematology, Spain, Distribution Share by Revenue ($mn), 2007-2008
- Table 84: Histology And Cytology, Spain, Distribution Share by Revenue ($mn), 2007-2008
- Table 85: Immuno Chemistry, Spain, Distribution Share by Revenue ($mn), 2007-2008
- Table 86: Infectious Immunology, Spain, Distribution Share by Revenue ($mn), 2007-2008
- Table 87: Microbiology Culture, Spain, Distribution Share by Revenue ($mn), 2007-2008
- Table 88: In Vitro Diagnostics, Spain, Company Share by Revenue ($ mn), 2007-2008
- Table 89: Clinical Chemistry, Spain, Company Share by Revenue ($ mn), 2007-2008
- Table 90: Genetic Testing, Spain, Company Share by Revenue ($ mn), 2007-2008
- Table 91: Haematology, Spain, Company Share by Revenue ($ mn), 2007-2008
- Table 92: Histology And Cytology, Spain, Company Share by Revenue ($ mn), 2007-2008
- Table 93: Immuno Chemistry, Spain, Company Share by Revenue ($ mn), 2007-2008
- Table 94: Infectiozus Immunology, Spain, Company Share by Revenue ($ mn), 2007-2008
- Table 95: Microbiology Culture, Spain, Company Share by Revenue ($ mn), 2007-2008
- Table 96: In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), 2000-2015
- Table 97: In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), Historic, 2000-2008
- Table 98: In Vitro Diagnostics, Netherlands, Overall Revenue ($ mn), Forecast, 2008-2015
- Table 99: Clinical Chemistry, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
- Table 100: Genetic Testing, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
- Table 101: Haematology, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
- Table 102: Histology And Cytology, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
- Table 103: Immuno Chemistry, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
- Table 104: Infectious Immunology, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
- Table 105: Microbiology Culture, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
- Table 106: In Vitro Diagnostics, Netherlands, Company Share by Revenue ($ mn), 2007-2008
- Table 107: Clinical Chemistry, Netherlands, Company Share by Revenue ($ mn), 2007-2008
- Table 108: Genetic Testing, Netherlands, Company Share by Revenue ($ mn), 2007-2008
- Table 109: Haematology, Netherlands, Company Share by Revenue ($ mn), 2007-2008
- Table 110: Histology And Cytology, Netherlands, Company Share by Revenue ($ mn), 2007-2008
- Table 111: Immuno Chemistry, Netherlands, Company Share by Revenue ($ mn), 2007-2008
- Table 112: Infectious Immunology, Netherlands, Company Share by Revenue ($ mn), 2007-2008
- Table 113: Microbiology Culture, Netherlands, Company Share by Revenue ($ mn), 2007-2008
- Table 114: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), 2000-2015
- Table 115: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), Historic, 2000-2008
- Table 116: In Vitro Diagnostics, Belgium, Overall Revenue ($ mn), Forecast, 2008-2015
- Table 117: Clinical Chemistry, Belgium, Distribution Share by Revenue ($mn), 2007-2008
- Table 118: Genetic Testing, Belgium, Distribution Share by Revenue ($mn), 2007-2008
- Table 119: Haematology, Belgium, Distribution Share by Revenue ($mn), 2007-2008
- Table 120: Histology And Cytology, Belgium, Distribution Share by Revenue ($mn), 2007-2008
- Table 121: Immuno Chemistry, Belgium, Distribution Share by Revenue ($mn), 2007-2008
- Table 122: Infectious Immunology, Belgium, Distribution Share by Revenue ($mn), 2007-2008
- Table 123: Microbiology Culture, Belgium, Distribution Share by Revenue ($mn), 2007-2008
- Table 124: In Vitro Diagnostics, Belgium, Company Share by Revenue ($ mn), 2007-2008
- Table 125: Clinical Chemistry, Belgium, Company Share by Revenue ($ mn), 2007-2008
- Table 126: Genetic Testing, Belgium, Company Share by Revenue ($ mn), 2007-2008
- Table 127: Haematology, Belgium, Company Share by Revenue ($ mn), 2007-2008
- Table 128: Histology And Cytology, Belgium, Company Share by Revenue ($ mn), 2007-2008
- Table 129: Immuno Chemistry, Belgium, Company Share by Revenue ($ mn), 2007-2008
- Table 130: Infectious Immunology, Belgium, Company Share by Revenue ($ mn), 2007-2008
- Table 131: Microbiology Culture, Belgium, Company Share by Revenue ($ mn), 2007-2008
- Table 132: Sysmex Corporation Pipeline Products by Equipment Type
- Table 133: Sysmex Corporation Pipeline Products By Development Stage
- Table 134: Sysmex Corporation Pipeline Products By Therapy Area
- Table 135: Qiagen N.V. Pipeline Products by Equipment Type
- Table 136: Qiagen N.V. Pipeline Products By Development Stage
- Table 137: Qiagen N.V. Pipeline Products By Therapy Area
- Table 138: Phadia AB Pipeline Products by Equipment Type
- Table 139: Phadia AB Pipeline Products By Development Stage
- Table 140: Phadia AB Pipeline Products By Therapy Area
- Table 141: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type
- Table 142: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage
- Table 143: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area
- Table 144: Ortho-Clinical Diagnostics Inc. Pipeline Products By Clinical Trials
- Table 145: Mindray Medical International Limited Pipeline Products by Equipment Type
- Table 146: Mindray Medical International Limited Pipeline Products By Development Stage
- Table 147: Mindray Medical International Limited Pipeline Products By Therapy Area
- Table 148: Inverness Medical Innovations, Inc. Pipeline Products by Equipment Type
- Table 149: Inverness Medical Innovations, Inc. Pipeline Products By Development Stage
- Table 150: Inverness Medical Innovations, Inc. Pipeline Products By Therapy Area
- Table 151: Inverness Medical Innovations, Inc. Pipeline Products By Clinical Trials
- Table 152: Hologic, Inc. Pipeline Products by Equipment Type
- Table 153: Hologic, Inc. Pipeline Products By Development Stage
- Table 154: Hologic, Inc. Pipeline Products By Therapy Area
- Table 155: Gen-Probe Incorporated Pipeline Products by Equipment Type
- Table 156: Gen-Probe Incorporated Pipeline Products By Development Stage
- Table 157: Gen-Probe Incorporated Pipeline Products By Therapy Area
- Table 158: Gen-Probe Incorporated Pipeline Products By Clinical Trials
- Table 159: DiaSorin S.p.A Pipeline Products by Equipment Type
- Table 160: DiaSorin S.p.A Pipeline Products By Development Stage
- Table 161: DiaSorin S.p.A Pipeline Products By Therapy Area
- Table 162: Biomerieux Sa Pipeline Products by Equipment Type
- Table 163: Biomerieux Sa Pipeline Products By Development Stage
- Table 164: Biomerieux Sa Pipeline Products By Therapy Area
- Table 165: Biomerieux Sa Pipeline Products By Clinical Trials
- Table 166: Becton, Dickinson and Company Pipeline Products by Equipment Type
- Table 167: Becton, Dickinson and Company Pipeline Products By Development Stage
- Table 168: Becton, Dickinson and Company Pipeline Products By Therapy Area
- Table 169: Beckman Coulter, Inc. Pipeline Products by Equipment Type
- Table 170: Beckman Coulter, Inc. Pipeline Products By Development Stage
- Table 171: Beckman Coulter, Inc. Pipeline Products By Therapy Area
- Table 172: Abbott Laboratories Pipeline Products by Equipment Type
- Table 173: Abbott Laboratories Pipeline Products By Development Stage
- Table 174: Abbott Laboratories Pipeline Products By Therapy Area
- Table 175: Lab21 Acquires Delphic Diagnostic From BDO
- Table 176: International SOS Acquires Majority Stake In Abermed
- Table 177: Bio-Rad Laboratories To Acquire Medical Diagnostics Segment From Biotest
- Table 178: ERBA DIAGNOSTICS MANNHEIM Acquires PLIVA-Lachema Diagnostika
- Table 179: Thermo Fisher Scientific Completes Acquisition Of B.R.A.H.M.S.
- Table 180: QIAGEN Completes Acquisition Of DxS
- Table 181: Legal & General Ventures To Sell LGC
- Table 182: LinkMed To Acquire 51% Stake In AbSorber From Koncentra And Jan Holgersson
- Table 183: North Atlantic Value Completes Acquisition Of Celsis International
- Table 184: The Riverside Acquires Crioestaminal Saude e Tecnologia
- Table 185: Curetis Secures $27.89 Million In Series A Round Of Financing
- Table 186: Biomedical Diagnostics Secures $4.52 Million In Financing
- Table 187: Pronota Secures Additional $1.92 Million In Series B Round Of Financing
- Table 188: Biocartis Secures $14.9 Million In Series A Equity Round Of Financing
- Table 189: mtm laboratories Secures $10.21 Million In Fourth Tranche Of Series C Financing Round
- Table 190: Kreatech Diagnostics Secures $2.86 Million In Financing Round
- Table 191: Agendia Raises $23 Million In Series E Financing
- Table 192: ExonHit Therapeutics Plans Rights Issue Of New Shares For $25.67 Million
- Table 193: Osmetech Announces Private Placement Of Shares For $16.3 Million
- Table 194: Mediwatch Completes Private Placement Of $0.57 Million
- Table 195: QIAGEN Completes Private Placement Of Its Common Stock For $640 Million
- Table 196: HairDX Enters Into Distribution Agreement With Svenson Haar Studios
- Table 197: MabCure Signs Research Agreement With AZ Sint-Lucas
- Table 198: USD to Local Currency, Average Exchange Rate 2008
- 1.2 List of Figures
- Figure 1: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), 2000-2015
- Figure 2: Europe In Vitro Diagnostics Market, Cross-Category Analysis, 2000-2015
- Figure 3: In Vitro Diagnostics, Europe, Overall Revenue ($ mn), Historic, 2000-2008
- Figu
More Europe General In Vitro Diagnostics Reports
2012 Italy Hemostasis Diagnostics Market Outlook: Growth Opportunities and Strategies by
Venture Planning Group
Report Highlights Comprehensive 402-page analysis of the Italian hemostasis market. Major issues pertaining to the Italian hemostasis laboratory practice, as well as key economic, regulatory, demographic, social ...
2012 Germany Hemostasis Diagnostics Market Outlook: Growth Opportunities and Strategies by
Venture Planning Group
Report Highlights Comprehensive 406-page analysis of the German hemostasis market, including: Major issues pertaining to the German hemostasis laboratory practice, as well as key economic, regulatory, demographic, ...
The 2012 Therapeutic Drug Monitoring Market: US, Europe, JapanTest Volume and Sales Forecasts by Country and Market Segment by
Venture Planning Group
During the next decade, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; ...
The 2012 Immunoprotein Diagnostics Market: US, Europe, JapanTest Volume and Sales Forecasts by Country and Market Segment by
Venture Planning Group
During the next decade, the immunoprotein testing market will undergo significant transformation. The changes will be caused by convergence of new and more stringent ...
The 2012 Hepatitis Diagnostics Market: US, Europe, JapanTest Volume, Sales Forecasts and Supplier Shares by Country by
Venture Planning Group
The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...
See all reports like this >>
More Europe Reports
A Comprehensive Study Of The UK Video Conferencing Equipment Market In 2010, Rating & Valuing Each Of The 30 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Tableware Market In 2010, Rating & Valuing Each Of The 166 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Surveyors & Valuers Market In 2010, Rating & Valuing Each Of The 943 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Subsea Engineering Market In 2010, Rating & Valuing Each Of The 142 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
A Comprehensive Study Of The UK Structural Engineering Consultancy Market In 2010, Rating & Valuing Each Of The 300 Companies That Operate In Today's Market by
Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...
See all reports like this >>
Share this report
Other tasks Related Markets General In Vitro Diagnostics Reports- In Vitro Diagnostics - A Global Market Overview
- In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018
- Clinical Lab Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
- Immunochemistry Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
- Diagnostic Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
